Clinical Trial Update: Study of Trimebutine Maleate (NEWBUTIN SR 300 mg Tab)for Treatment of Post Operative Nausea and Vomiting [Phase 3]

View source ↗

Summary

Clinical trial update for Trimebutine Maleate (NEWBUTIN SR 300 mg) investigating postoperative nausea and vomiting in Phase 3; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Nausea and Vomiting

Drugs mentioned

• NEWBUTIN SR 300 mg Tab (trimebutine maleate)

Snippet

Sponsor: CM Chungmu Hospital | Conditions: Nausea, Vomiting | Phase 3 | Status: UNKNOWN